4//SEC Filing
Nallicheri Melanie 4
Accession 0001104659-23-001123
CIK 0001843762other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:58 PM ET
Size
8.7 KB
Accession
0001104659-23-001123
Insider Transaction Report
Form 4
EQRx, Inc.EQRX
Nallicheri Melanie
DirectorChief Executive Officer
Transactions
- Award
Earn-out Shares
2023-01-01+2,777→ 530,335 total(indirect: By LLC)Exp: 2024-12-17→ Common Stock (2,777 underlying) - Award
Earn-out Shares
2023-01-01+5,453→ 1,041,108 totalExp: 2024-12-17→ Common Stock (5,453 underlying)
Footnotes (2)
- [F1]On January 1, 2023, the Reporting Person was allocated the right to acquire an additional 8,230 shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 5,760 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 2,470 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the Reporting Person may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.).
- [F2]Shares held by MIN 2020 LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
Documents
Issuer
EQRx, Inc.
CIK 0001843762
Entity typeother
Related Parties
1- filerCIK 0001710655
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:58 PM ET
- Size
- 8.7 KB